ACCURAY INCORPORATED Equity Method Investment, Deferred Gain on Sale
ACCURAY INCORPORATED (ARAY) reported Equity Method Investment, Deferred Gain on Sale of $139.00 thousand for the 6-month period ending 2025-12-31, per its 10-Q filed 2026-02-17.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentDeferredGainOnSale · last filed 2026-02-17
- 2025-12-31: Equity Method Investment, Deferred Gain on Sale 6 month $139.00K.
- 2024-12-31: Equity Method Investment, Deferred Gain on Sale 6 month $894.00K.
| Period end | Equity Method Investment, Deferred Gain on Sale 6 month |
|---|---|
| 2025-12-31 | $139.00K 10-Q · filed 2026-02-17 |
| 2024-12-31 | $894.00K 10-Q · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |